Paying HCPs Compliantly, Part 2: Global and International Payment Considerations

Why paying HCPs correctly gets harder, not easier, once your engagements cross a border — and what a defensible global payment program looks like.

Part 1 of this series looked at what it takes to pay HCPs compliantly inside the United States: FMV methodology, payment ownership and timing, and Sunshine Act reporting alignment. For life sciences companies operating across multiple countries, the complexity of getting HCP payments right compounds considerably.

Outside the United States, the regulatory environment for HCP payments is not a single framework. It is a country-by-country matrix of statutes, regulations, self-regulatory industry codes, national association rules, public-hospital or employer requirements, privacy rules, tax rules, and company policy commitments. What is permissible in one market may not be in another, or may require different approvals, documentation, recipient consent, reporting treatment, or tax handling.

This piece is a governance overview of the recurring themes compliance teams need to account for when paying HCPs internationally. It is not a substitute for jurisdiction-specific legal advice.

Country-Specific Restrictions

Several recurring themes apply across markets:

• • Rate controls and benchmarks may come from law, national industry codes, company policy, local affiliate practice, or external FMV references. These sources should not be treated as interchangeable. A benchmark that is not legally binding may still become an important enforcement, audit, or reputational reference point if the company departs from it without documentation
  • Prior approval, notification, employer consent, or public-institution approval may apply before an engagement begins, not merely before payment is made. This is especially important when HCPs are employed by public hospitals, universities, or government-affiliated healthcare institutions
  • Activity-specific restrictions may apply. Speaking, advisory board participation, market research, training, research, sponsorship, and travel support can be treated differently within the same jurisdiction
  • Cross-border payments may require additional analysis around the appropriate contracting entity, payment entity, recipient location, service location, currency, withholding tax, and disclosure jurisdiction

Organizations that apply US-centric payment standards globally, without accounting for country-specific requirements, create compliance exposure that can be difficult to remediate retroactively.

Disclosure Requirements

The global transparency landscape should not be described as a single set of national transparency laws. The legal status of each regime matters. Some frameworks are statutory or regulatory. Others are self-regulatory industry codes. Others operate through voluntary member-company commitments or industry association rules. The distinction affects enforceability, escalation paths, consent requirements, publication method, recipient definitions, and remediation expectations. In addition to the US Sunshine Act, life sciences companies operating internationally should navigate:

• • EFPIA disclosure requirements and related national association codes across European markets, including country-specific implementation differences driven by local codes, legal requirements, data privacy rules, and disclosure platforms
  • Jurisdiction-specific transparency regimes in markets such as France, the UK, Germany, Japan, and others, where disclosure obligations may arise from statute, regulation, or industry self-regulatory codes, with varying definitions of covered recipients, reportable transfers of value, consent requirements, reporting timelines, and publication formats. France’s Transparence Santé framework, for example, is statutory and regulatory in nature, while UK disclosure obligations operate through the ABPI Code and Disclosure UK framework
  • Evolving transparency and disclosure expectations in additional markets across Asia-Pacific, Latin America, and the Middle East, where requirements may be statutory, code-based, or still developing; multinational companies must monitor local implementation closely

The operational implication is that the same payment may need to be captured, categorized, and disclosed differently depending on the country, recipient type, payment type, and applicable code or legal framework. Data collection, validation, and submission processes that work well for a single jurisdiction become significantly more complex at scale. A global system should support local data fields, local approval logic, local publication requirements, currency treatment, and country-specific documentation rather than forcing all markets into a single US-style reporting taxonomy.

Currency and Tax Implications

International HCP payments introduce additional compliance dimensions that often sit at the intersection of legal, finance, and tax functions, but that compliance programs cannot ignore:

• • Currency conversion must be handled consistently and documented, with a clear methodology for converting local currency payments into reporting currencies
  • Withholding tax requirements vary by country and can affect net payment amounts. The contract, invoice, payment record, and disclosure record should be consistent about gross amount, withholding, and net amount paid
  • Local invoicing requirements in some markets require that payments be processed through local entities, with specific documentation, rather than processed centrally
  • Data privacy and consent rules may affect how recipient-level information is collected, validated, retained, and disclosed

Compliance teams that treat international payment compliance as purely a legal or finance issue often end up managing exceptions rather than preventing them. A more resilient approach builds the relevant local controls directly into intake, contracting, payment, and reporting workflows.

Operational Realities of Global Payment Programs

The same operational weaknesses that create risk domestically, manual workflows, fragmented systems, and mismatches between contracted and documented services, are magnified across multiple countries, currencies, and disclosure regimes. Part 1 of this series covers those challenges in more depth. At global scale, the additional strain point is usually reconciliation: keeping payment records, engagement records, tax records, and transparency reporting consistent across every market a company operates in.

Best Practices for Global Payment Governance

Controls and Reconciliation

Reconciliation should not be a once-per-year exercise, and it becomes more important, not less, once payments cross borders. Organizations that build monthly or quarterly reconciliation into their global payment workflows catch currency, tax, and disclosure mismatches early, when they are easier to investigate, explain, and correct.

Audit Trails for International Payments

In addition to the standard audit-trail questions covered in Part 1, every international HCP payment should be able to answer:

• • What local approvals, notifications, or employer or public-institution consents were required before the engagement began?
  • What tax treatment, including withholding, applied to the payment?
  • What currency conversion methodology was used, and is it documented and consistently applied?
  • Under which country’s disclosure framework, or frameworks, was the payment categorized and reported?

Organizations that can answer those questions from structured records, without manual reconstruction from local email threads and shared drives, are operating at a level of governance maturity that is more likely to hold up under regulatory, internal audit, and external reviewer scrutiny in every market where they operate.

Practical Takeaways

International Payment Compliance Checklist

In addition to the core payment compliance items covered in Part 1, compliance teams should be able to affirm the following for every international HCP payment:

☐   Country-specific restrictions on the activity type have been identified and addressed

☐   Prior approval, notification, or public-institution consent has been obtained where required, before the engagement began

☐   The applicable disclosure framework, or frameworks, has been identified and the payment categorized accordingly

☐   Currency conversion has been handled using a documented, consistently applied methodology

☐   Withholding tax treatment is consistent across the contract, invoice, payment record, and disclosure record

☐   Local invoicing requirements have been met where payments must be processed through a local entity

☐   Data privacy and consent requirements for recipient-level information have been addressed

Red Flags Compliance Teams Watch For

In the international context, experienced compliance reviewers pay particular attention to:

• Engagements with HCPs in markets where the company has limited business presence or unclear legitimate business needs
• International payments processed outside established vendor systems or without country-specific documentation, tax, or disclosure review
• Transparency reporting corrections or amendments that recur across multiple reporting periods or multiple countries
• Gaps between contracted scope and documented deliverables that are explained informally rather than through a formal amendment or exception process

These are not necessarily indicators of wrongdoing. They are indicators of process weakness, and the same discipline that resolves them domestically- structured documentation, embedded controls, and consistent reconciliation- resolves them globally.

Getting Global Payment Compliance Right

The organizations that manage HCP payment compliance most effectively at global scale are not necessarily the ones with the most complex policies. They are the ones that have built payment governance directly into operational workflows, with embedded controls, systematic reconciliation, and reporting processes that connect payment data to engagement records across every geography in which they operate.

Payment compliance is one of the clearest ways an organization demonstrates that an engagement had a legitimate purpose, was documented appropriately, and was executed consistently with applicable law, code requirements, and policy expectations, wherever in the world that engagement took place.

How Medispend Helps

Global Compliance Digest

Medispend’s Global Compliance Digest is your definitive guide to the complex maze of life sciences compliance in the US and around the world. With real-time updates and access to over 70,000 regulatory data points, it puts timely, actionable, country-specific insight at your fingertips. Learn more about Global Compliance Digest →

Spend Transparency

Medispend’s Spend Transparency solutions help life sciences companies of all sizes meet global aggregate spend transparency regulations, offered as Reporting-as-a-Service, a full Transparency Solution (SaaS), or MediSpend Managed Services, so reporting scales with the number of markets you operate in. Learn more about Spend Transparency →

Get the full checklist

This article covers the international portion of the payment compliance checklist. Download the complete HCP Payment Compliance Audit-Readiness Checklist, covering both US and international payments, here: HCP Payment Compliance Audit-Readiness Checklist

Catch up on the series

Part 1: US Regulatory and Payment Considerations covers FMV methodology, payment ownership and timing, and Sunshine Act reporting alignment.

Have questions about your global payment compliance program? Contact Medispend →